We report for the first time that 5-hydroxytryptophan can be synthesized in Saccharomyces cerevisiae by heterologously expressing prokaryotic phenylalanine 4-hydroxylase or eukaryotic tryptophan 3/5-hydroxylase, together with enhanced synthesis of MH4 or BH4 cofactors. The innate DFR1 gene in the folate synthesis pathway was found to play pivotal roles in 5-hydroxytryptophan synthesis. 5-Hydroxytryptophan (5-HTP) is an intermediate in the biosynthesis of the neurotransmitter serotonin 1 and has been used in the clinic for over 30 years. 5-HTP can be easily absorbed by the human body and transported across the blood-brain barrier. 2 The therapeutic administration of 5-HTP has shown to be effective in treating depression as well as a wide variety of medical conditions, including fibromyalgia, insomnia, binge eating associated with obesity, cerebellar ataxia, and chronic headaches. 3 Nowadays, since chemical synthesis of 5-HTP is still economically infeasible, 5-HTP is mainly extracted from the seeds of the African plant Griffonia simplicifolia, 4-7 which, however, is largely limited by the season-and region-dependent supply of the raw materials.
Compared to E. coli, S. cerevisiae can tolerate harsher fermentation conditions and does not have a phage contamination issue. 9 Such a study, to the best of our knowledge, has not yet been accomplished and little is known about the pathways and cofactors involved in 5-HTP synthesis in eukaryotic organisms. Knowing the molecular basis of 5-HTP synthesis will not only help us understand the mechanisms of 5-HTP synthesis and regulation, but also provide a promising route for large-scale production of 5-HTP using recombinant S. cerevisiae as an industrial workhorse. This paper is a proof-of-concept study to reveal the molecular pathways that could lead to 5-HTP synthesis in S. cerevisiae. The significance of this work is that we discovered, to the best of our knowledge for the first time, that two metabolic pathways could lead to 5-HTP synthesis in S. cerevisiae.
To start, we surveyed some literatures and found two pathways that could potentially lead to 5-HTP synthesis in S. cerevisiae. The first pathway uses bacterial P4Hs for 5-HTP synthesis with MH4 used as the cofactor, 6 while the second pathway uses tryptophan 5-hydroxylase (T5H) or tryptophan 3-hydroxylase (T3H) to catalyze 5-HTP synthesis from L-tryptophan by using tetrahydrobiopterin (BH4) as the cofactor 10 ( Fig. 1 ). Since it has been confirmed in E. coli that bacterial P4Hs can use MH4 to synthesize 5-HTP, we first constructed the same bacterial pathway in S. cerevisiae using the DNA Assembler 4 method (Tables S1 and S2, ESI †). We used strong constitutive promoters to express the XcP4H gene (i.e., encoding an evolved P4H from X. campestris) and two genes for MH4 synthesis, i.e., folM gene encoding dihydromonapterin reductase (DHMR) from E. coli to convert dihydroxymonapetrin (MH2) to MH4; and phhB gene encoding pterin-4a-carbinolamine dehydratase from Pseudomonas aeruginosa to regenerate MH2. 6 We then transformed the plasmid to the S. cerevisiae BY4741 strain via LiAc-mediated yeast transformation, and cultured the recombinant yeast cells in SC medium with 2 g L À1 tryptophan and 1 mM ascorbic acid in shake flasks. We measured 5-HTP concentrations (Fig. 2) in the medium at 18 h, 28 h, and 72 h using an ELISA kit (Cloud-Clone Corp). As expected, we indeed detected 5-HTP produced by the recombinant S. cerevisiae strain, which was synthesized at 0.197 AE 0.001 mg L À1 , 0.429 AE 0.163 mg L À1 , and 0.337 AE 0.187 mg L À1 at 18 h, 28 h, and 72 h, respectively. Compared to the control S. cerevisiae strain that only expressed an empty pRS415 plasmid, the 5-HTP concentrations detected at all of the time points were significantly higher ( p o 0.001). The decreased synthesis of 5-HTP at 72 h was possibly due to the degradation of 5-HTP after the long-time culture in aerobic conditions since 5-HTP is sensitive to oxidation.
Interestingly, we also found that a native S. cerevisiae gene, DFR1, which encodes dihydrofolate reductase to catalyze tetrahydrofolate synthesis, had a similar role as the folM gene in E. coli, by surveying the KEGG database and BioCyc database. Considering the bifurcated role of the folM gene in recycling MH4 from MH2, we hypothesized that the DFR1 gene may also have similar function for MH4 synthesis. To test our hypothesis, we constructed a series of recombinant S. cerevisiae strains (Table S1, ESI †). As shown in Fig. 3 , when we knocked out the DFR1 gene (Ddfr1) and only expressed XcP4H, the 5-HTP synthesis significantly dropped ( p o 0.04) from 2.382 AE 0.255 mg per L per OD to 0.520 AE 0.235 mg per L per OD because of the lack of the capability to generate MH4. Then, when we co-expressed the DFR1 gene along with XcP4H in the context of the forenamed Ddfr1 knock-out mutant, the 5-HTP synthesis was fully restored, indicating that the DFR1 gene could supply MH4 for 5-HTP synthesis. When we further expressed the DFR1 gene in the Ddfr1 mutant with expression of both XcP4H and folM, the 5-HTP synthesis was slightly increased, which again suggested a positive role of the DFR1 gene in 5-HTP synthesis. Taken together, we confirmed that the DFR1 gene played a pivotal role in 5-HTP synthesis in S. cerevisiae by regenerating MH4. It is also worth noting that the removal of the DFR1 gene did not completely shut down the 5-HTP synthesis, indicating the presence of other innate MH4-regenerating enzymes in S. cerevisiae.
In addition to expressing bacterial P4Hs for 5-HTP synthesis with MH4 used as the cofactor, we also explored another possible pathway for 5-HTP synthesis by using eukaryotic genes. 5-HTP is natively produced in humans and animals from L-tryptophan and serves as an important hormone for humans and some animals. The synthesis of 5-HTP was catalysed by tryptophan 5-hydroxylase (T5H) or tryptophan 3-hydroxylase (T3H), 11 both of which use BH4 as the coenzyme. The BH4 recycling pathway was encoded by sepiapterin reductase (SPR) to catalyze the synthesis of BH4 from 6-pyruvoyltetrahydropterin (6PTH), 12 as well as pterin-4-alpha-carbinolamine dehydratase (PCBD) and dihydropteridine reductase (DHPR) to regenerate BH2 and BH4. 13, 14 In addition, GTP cyclohydrolase 1 (GCH) and 6-pyruvoyltetrahydropterin synthase (PTS) could produce 6PTH to enhance BH4 supply. To comprehensively explore the potential for 5-HTP synthesis in S. cerevisiae, we surveyed various hydroxylases in addition to XcP4H, including P4H from Fig. 3 The role of the DFR1 gene in 5-HTP synthesis. All of the samples were measured at 72 h in triplicate. Basically, we measured the concentration of 5-HTP produced in yeast as mg L À1 . In the meantime, we used the OD600 to measure the cell density. Therefore, the unit of mg per L per OD indicated the cell-based 5-HTP yields in S. cerevisiae.
Burkholderia pseudomallei (BpP4H); P4H from Mesorhizobium ciceri biovar biserrulae (McP4H); T5H from Oryctolagus cuniculu (OcT5H); a truncated version of OcT5H (OcT5Ht); T5H from Schistosoma mansoni (SmT5H); P4H from Oryctolagus cuniculus (OcP4H); and T3H from Homo sapiens (HsT3H). We also constructed a MH4 biosynthesis pathway by expressing folM from E. coli and phhb from P. aeruginosa; and a BH4 biosynthesis pathway by expressing PTS and SPR from Rattus norvegicus, DHPR and GCH from E. coli, and PCBD from P. aeruginosa in pRS416 plasmids of S. cerevisiae, respectively (Table S1, ESI †). We then combined different hydroxylases with either the MH4 or BH4 biosynthesis pathway, and characterized the 5-HTP synthesis at 72 h by cultivating the recombinant S. cerevisiae strains in SC medium with 2 g L À1 tryptophan and 1 mM ascorbic acid in shake flasks (Fig. 4 ). We found that OcT5H and SmT5H using BH4 as cofactors were the top 2 hydroxylases that led to over a 17 fold increase of 5-HTP synthesis compared to that of XcP4H using MH4 as cofactors. Except for HsT3H, BH4 was preferred to being used as the cofactors by all of the hydroxylases for 5-HTP synthesis in S. cerevisiae, even for those from bacteria (i.e., XcP4H, BpP4H, McP4H, and OcP4H). The flexibility of using either MH4 or BH4 as the cofactors might due to their similar structures and/or the low substrate specificity of different hydroxylases.
We also applied western blotting to characterize the expression levels of XcP4H, BpP4H, OcT5H, and SmT5H. These four enzymes were chosen since XcP4H and BpP4H led to the lowest production of 5-HTP in yeast while OcT5H and SmT5H led to the highest production. As shown in Fig. S1 (ESI †), we found that the expression levels of different enzymes varied but were not positively correlated with the 5-HTP synthesis. For example, OcT5H had a similar expression level as BpP4H but led to >7 fold higher production of 5-HTP when using BH4 as the cofactor. SmT5H had a higher expression level than OcT5H but led to a similar amount of 5-HTP being produced when using BH4 as the cofactor. In addition, we measured the in vitro enzyme activities of XcP4H, BpP4H, OcT5H, and SmT5H. As shown in Fig. S2 (ESI †) , we found that all of the enzymes demonstrated higher activities when using BH4 as the cofactor. The activities of OcT5H and SmT5H were 50-75% higher than that of XcP4H and BpP4H when using BH4 as the cofactor. Taken together, the western blotting and the measurement of in vitro enzyme activities indicated that T5Hs could be a better candidate when applying metabolic engineering to improve 5-HTP production in yeast.
To conclude, in this study, we discovered that two pathways could lead to 5-HTP synthesis in S. cerevisiae, by using either MH4 or BH4 as the cofactor and the innate DFR1 gene in S. cerevisiae was critical in recycling MH4 for 5-HTP synthesis. It is the first time, to the best of our knowledge, that the molecular basis of 5-HTP synthesis was revealed in a eukaryotic organism, which paves the ways for future metabolic engineering (e.g., increasing the supply of tryptophan precursor and cofactors) to promote yeast-based production of 5-HTP.
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